1. Home
  2. IART vs SPTX Comparison

IART vs SPTX Comparison

Compare IART & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

SELL

Current Price

$14.10

Market Cap

951.9M

Sector

Health Care

ML Signal

SELL

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

SELL

Current Price

$19.35

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IART
SPTX
Founded
1989
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
951.9M
1.1B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
IART
SPTX
Price
$14.10
$19.35
Analyst Decision
Hold
Strong Buy
Analyst Count
12
9
Target Price
$15.67
★ $37.13
AVG Volume (30 Days)
★ 1.1M
249.2K
Earning Date
10-21-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.19
N/A
Revenue
N/A
N/A
Revenue This Year
$0.55
N/A
Revenue Next Year
$1.86
N/A
P/E Ratio
$73.58
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.70
$15.79
52 Week High
$20.49
$28.38

Technical Indicators

Market Signals
Indicator
IART
SPTX
Relative Strength Index (RSI) 51.45 43.36
Support Level $11.96 $18.79
Resistance Level $14.28 $22.57
Average True Range (ATR) 0.78 1.47
MACD 0.20 -0.09
Stochastic Oscillator 64.61 13.67

Price Performance

Historical Comparison
IART
SPTX

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: